SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037239
Filing Date
2020-08-06
Accepted
2020-08-06 07:14:38
Documents
76
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ortx-10q_20200630.htm   iXBRL 10-Q 3436364
2 EX-10.1 ortx-ex101_173.htm EX-10.1 694741
3 EX-31.1 ortx-ex311_6.htm EX-31.1 17933
4 EX-31.2 ortx-ex312_7.htm EX-31.2 17906
5 EX-32.1 ortx-ex321_11.htm EX-32.1 12416
  Complete submission text file 0001564590-20-037239.txt   12009656

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ortx-20200630.xsd EX-101.SCH 59340
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ortx-20200630_cal.xml EX-101.CAL 61851
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ortx-20200630_def.xml EX-101.DEF 163745
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20200630_lab.xml EX-101.LAB 457705
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20200630_pre.xml EX-101.PRE 347203
11 EXTRACTED XBRL INSTANCE DOCUMENT ortx-10q_20200630_htm.xml XML 2301836
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38722 | Film No.: 201079786
SIC: 2836 Biological Products, (No Diagnostic Substances)